MedKoo Cat#: 112035 | Name: DAPK Substrate Peptide TFA salt
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DAPK substrate peptide is a peptide substrate which has been used as a target substrate for quantification of death-associated protein kinase 1 (DAPK1). DAPK1 is a serine/threonine kinase involved in apoptosis and tumor suppression.

Chemical Structure

DAPK Substrate Peptide TFA salt
DAPK Substrate Peptide TFA salt
CAS#NONE

Theoretical Analysis

MedKoo Cat#: 112035

Name: DAPK Substrate Peptide TFA salt

CAS#: NONE

Chemical Formula: C72H116F3N25O19

Exact Mass: 0.0000

Molecular Weight: 1692.87

Elemental Analysis: C, 51.08; H, 6.91; F, 3.37; N, 20.69; O, 17.96

Price and Availability

Size Price Availability Quantity
1mg USD 300.00 Back order
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
DAPK Substrate Peptide trifluoroacetate salt; DAPK Substrate Peptide (TFA salt); DAPK Substrate Peptide (trifluoroacetate salt); Death-associated Protein Kinase Substrate Peptide
IUPAC/Chemical Name
L-lysyl-L-lysyl-L-arginyl-L-prolyl-L-glutaminyl-L-arginyl-L-arginyl-L-tyrosyl-L-seryl-L-asparaginyl-L-valyl-L-phenylalanine compound with 2,2,2-trifluoroacetic acid (1:1)
InChi Key
OXBPXENUMMRMRE-HPBSDWBESA-N
InChi Code
InChI=1S/C70H115N25O17.C2HF3O2/c1-38(2)55(65(109)92-50(67(111)112)35-39-14-4-3-5-15-39)94-62(106)49(36-54(75)99)91-63(107)51(37-96)93-61(105)48(34-40-22-24-41(97)25-23-40)90-59(103)45(19-11-31-83-69(78)79)86-57(101)44(18-10-30-82-68(76)77)87-60(104)46(26-27-53(74)98)88-64(108)52-21-13-33-95(52)66(110)47(20-12-32-84-70(80)81)89-58(102)43(17-7-9-29-72)85-56(100)42(73)16-6-8-28-71;3-2(4,5)1(6)7/h3-5,14-15,22-25,38,42-52,55,96-97H,6-13,16-21,26-37,71-73H2,1-2H3,(H2,74,98)(H2,75,99)(H,85,100)(H,86,101)(H,87,104)(H,88,108)(H,89,102)(H,90,103)(H,91,107)(H,92,109)(H,93,105)(H,94,106)(H,111,112)(H4,76,77,82)(H4,78,79,83)(H4,80,81,84);(H,6,7)/t42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,55-;/m0./s1
SMILES Code
CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N.C(=O)(C(F)(F)F)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,692.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL